Pfizer: Independent Grants for Learning and Change (IGLC) - Musculoskeletal Ultrasound in Hemophilia

Pfizer, Inc. is interested in funding projects that enable the training of clinical providers in musculoskeletal ultrasound in hemophilia. Awards can be for up to $300,000. Application deadline is Jan. 25, 2016.

The UNC Office of Corporate and Foundation Relations has identified the following private funding opportunity:

Pfizer, Inc - Independent Grants for Learning and Change (IGLC) - Musculoskeletal Ultrasound in Hemophilia
http://www.pfizer.com

Pfizer, Inc. is interested in funding projects that enable the training of clinical providers such as physicians (including residents and fellows), physical therapists, nurses and nurse practitioners in musculoskeletal ultrasound in hemophilia (MSKUS). Pfizer seeks to provide funding for programs that offer training in the new technology. Priority will be given to existing centers that have already adopted MSKUS and have a goal of expanding their capacity to extend the reach of their training program.

Application Deadline: Jan. 25, 2016. Application guidelines are found here.

The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. Email cfr@unc.edu or phone 919-962-3423. 

Filed under: